NCT01707537

To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men

Phase I Study to Determine the Safety and Immunogenicity of Euvichol(Oral Cholera Prevention Vaccine)in Healthy Adult Men ; Open, Non-comparative Clinical Trial

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: EuBiologics Co.,Ltd · Industry
• Sex: Male
• Age: 20 Years
• Healthy volunteers: Accepted

Summary

To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men

Detailed description

This clinical trial is open, non-comparative phase 1 clinical studies in healthy men and has been designed to determine the safety and immunogenicity of Euvichol(Oral cholera vaccine)

Conditions

• Prevention Harmful Effects

Interventions

Type	Name	Description
BIOLOGICAL	Euvichol	1.5mL/vial, 1vial at 2-week intervals twice

Timeline

• Start date: 2012-09-01
• Primary completion: 2013-02-01
• Completion: 2013-02-01
• First posted: 2012-10-16
• Last updated: 2013-02-20

Locations

1 site across 1 country: South Korea